Mike has developed expertise across a range of therapeutic areas in his decade-long career in the life science commercialization space. This has involved leading a range of engagements with a diverse set of life science companies spanning products, franchises, and therapeutic areas. Mike has developed a particular focus in oncology and rare disease. He has extensive experience in the vaccine space in both commercial vaccines and stockpiled and pandemic vaccines. Mike has also developed a particular expertise in product planning and portfolio strategy as well as launch readiness, commercialization strategy, and diligence support.
Prior to joining ClearView, Mike completed a Ph.D. in Biochemistry from Wake Forest University. After receiving his doctorate, Mike completed a postdoctoral fellowship with the NIH in DNA mismatch repair and has extensive commercialization experience from his time leading sales and marketing in the U.S. and Canada with a life science instrumentation manufacturer.
Debbi Amanti Belanger